|
Originally published In Press as doi:10.1074/jbc.M605912200 on October 10, 2006
J. Biol. Chem., Vol. 281, Issue 48, 36742-36751, December 1, 2006
Identification and Characterization of a 1,3-Glucosyltransferase That Synthesizes the Glc- 1,3-Fuc Disaccharide on Thrombospondin Type 1 Repeats*
Krisztina Kozma ,
Jeremy J. Keusch ,
Björn Hegemann 1,
Kelvin B. Luther ,
Dominique Klein ,
Daniel Hess ,
Robert S. Haltiwanger , and
Jan Hofsteenge 2
From the
Friedrich Miescher Institute, Maulbeerstrasse 66, CH-4058 Basel, Switzerland and Department of Biochemistry and Cell Biology, Institute for Cell and Developmental Biology, Stony Brook University, Stony Brook, New York 11794-5215
Thrombospondin type 1 repeats (TSRs) are biologically important domains of extracellular proteins. They are modified with a unique Glc 1,3Fuc 1-O-linked disaccharide on either serine or threonine residues. Here we identify the putative glycosyltransferase, B3GTL, as the 1,3-glucosyltransferase involved in the biosynthesis of this disaccharide. This enzyme is conserved from Caenorhabditis elegans to man and shares 28% sequence identity with Fringe, the 1,3-N-acetylglucosaminyltransferase that modifies O-linked fucosyl residues in proteins containing epidermal growth factor-like domains, such as Notch. 1,3-Glucosyltransferase glucosylates properly folded TSR-fucose but not fucosylated epidermal growth factor-like domain or the non-fucosylated modules. Specifically, the glucose is added in a 1,3-linkage to the fucose in TSR. The activity profiles of 1,3-glucosyltransferase and protein O-fucosyltransferase 2, the enzyme that carries out the first step in TSR O-fucosylation, superimpose in endoplasmic reticulum subfractions obtained by density gradient centrifugation. Both enzymes are soluble proteins that efficiently modify properly folded TSR modules. The identification of the 1,3-glucosyltransferase gene allows us to manipulate the formation of the rare Glc 1,3Fuc 1 structure to investigate its biological function.
Received for publication, June 20, 2006
, and in revised form, September 6, 2006.
* This work was supported in part by National Institutes of Health Grant GM61126. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Present address: Research Institute of Molecular Pathology, Dr. Bohr-Gasse 7, 1030 Vienna, Austria.
2 To whom correspondence should be addressed. Tel.: 41-61-6974722; Fax: 41-61-6973976; E-mail: jan.hofsteenge{at}fmi.ch.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. L Lee, J. J Kohler, and S. R Pfeffer
Association of {beta}-1,3-N-acetylglucosaminyltransferase 1 and {beta}-1,4-galactosyltransferase 1, trans-Golgi enzymes involved in coupled poly-N-acetyllactosamine synthesis
Glycobiology,
June 1, 2009;
19(6):
655 - 664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F Valliere-Douglass, L. J Brady, C. Farnsworth, D. Pace, A. Balland, A. Wallace, W. Wang, M. J Treuheit, and B. Yan
O-Fucosylation of an antibody light chain: Characterization of a modification occurring on an IgG1 molecule
Glycobiology,
February 1, 2009;
19(2):
144 - 152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Luther, H. Schindelin, and R. S. Haltiwanger
Structural and Mechanistic Insights into Lunatic Fringe from a Kinetic Analysis of Enzyme Mutants
J. Biol. Chem.,
January 30, 2009;
284(5):
3294 - 3305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Hess, J. J. Keusch, S. A. L. Oberstein, R. C. M. Hennekam, and J. Hofsteenge
Peters Plus Syndrome Is a New Congenital Disorder of Glycosylation and Involves Defective O-Glycosylation of Thrombospondin Type 1 Repeats
J. Biol. Chem.,
March 21, 2008;
283(12):
7354 - 7360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Shi, C. Ge, Y. Luo, X. Hou, R. S. Haltiwanger, and P. Stanley
The Threonine That Carries Fucose, but Not Fucose, Is Required for Cripto to Facilitate Nodal Signaling
J. Biol. Chem.,
July 13, 2007;
282(28):
20133 - 20141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Ricketts, M. Dlugosz, K. B. Luther, R. S. Haltiwanger, and E. M. Majerus
O-Fucosylation Is Required for ADAMTS13 Secretion
J. Biol. Chem.,
June 8, 2007;
282(23):
17014 - 17023.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. W. Wang, M. Dlugosz, R. P. T. Somerville, M. Raed, R. S. Haltiwanger, and S. S. Apte
O-Fucosylation of Thrombospondin Type 1 Repeats in ADAMTS-like-1/Punctin-1 Regulates Secretion: IMPLICATIONS FOR THE ADAMTS SUPERFAMILY
J. Biol. Chem.,
June 8, 2007;
282(23):
17024 - 17031.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|